| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on December 15, 2006
From the VA Palo Alto Health Care System (P.A.H., P.G., A.S., M.K.G.) and Department of Medicine, Stanford University (P.A.H., M.K.G.), Stanford, Calif; and San Francisco VA Medical Center and Department of Medicine, University of California at San Francisco (B.M.), San Francisco, Calif. * To whom correspondence should be addressed. E-mail: heiden{at}stanford.edu.
Background--Although Methods and Results--We randomized 1546 consecutive patients with a left ventricular ejection fraction <45% found on echocardiography at 1 of 3 laboratories to a reminder for use of Conclusions--A reminder attached to the echocardiography report increased the use of
Accepted on April 3, 2007
Clinical Reminders Attached to Echocardiography Reports of Patients With Reduced Left Ventricular Ejection Fraction Increase Use of
Paul A. Heidenreich MD, MS*,
-Blockers. A Randomized Trial
-blockers are known to prolong survival for patients with reduced left ventricular ejection fraction, they are often underused. We hypothesized that a reminder attached to the echocardiography report would increase the use of
-blockers for patients with reduced left ventricular ejection fraction.
-blockers or no reminder. Patients were excluded from analysis if they died within 30 days of randomization (n=89), did not receive medications through the Veterans Affairs system after 30 days (n=180), or underwent echocardiography at >1 laboratory (n=6). The primary outcome was a prescription for an oral
-blocker between 1 and 9 months after randomization. The mean age of the 1271 included patients was 69 years; 60% had a history of heart failure, and 51% were receiving treatment with
-blockers at the time of echocardiography. More patients randomized to the reminder had a subsequent
-blocker prescription (74%, 458 of 621) compared with those randomized to no reminder (66%, 428 of 650; P=0.002). The effect of the reminder was not significantly different for subgroups based on patient location (inpatient versus outpatient) or prior use of
-blockers.
-blockers in patients with depressed left ventricular systolic function.
Related Article:
Circulation 2007 115: 2789.
This article has been cited by other articles:
![]() |
M. A. Hlatky and P. A. Heidenreich The Year in Epidemiology, Health Services Research, and Outcomes Research J. Am. Coll. Cardiol., April 21, 2009; 53(16): 1459 - 1466. [Full Text] [PDF] |
||||
![]() |
H. M. Krumholz Outcomes Research: Generating Evidence for Best Practice and Policies Circulation, July 15, 2008; 118(3): 309 - 318. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |